Your browser doesn't support javascript.
loading
Associations of nirmatrelvir-ritonavir treatment with death and clinical improvement in hospitalized patients with COVID-19 during the Omicron wave in Beijing, China: a multicentre, retrospective cohort study.
Han, Xiaobo; Li, Chenglong; Yuan, Xin; Cui, Junchang; Han, Zhihai; Meng, Jiguang; Zhao, Weiguo; Xie, Fei; Wang, Kaifei; Liu, Yuhong; Muo, Guoxin; Xi, Na; Zheng, Mengli; Wang, Rentao; Xiao, Kun; Chen, Wei; Xiong, Junchen; Zhao, Dahui; Zhang, Xinxin; Han, Xinjie; Cheng, Haibo; Yu, Zhongkuo; Shi, Yinghan; Xie, Wuxiang; Xie, Lixin.
Affiliation
  • Han X; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Li C; Chinese PLA Medical School, Beijing, China.
  • Yuan X; National Institute of Health Data Science, Peking University, Beijing, China.
  • Cui J; Institute of Medical Technology, Health Science Center of Peking University, Beijing, China.
  • Han Z; Pulmonary and Critical Care Medicine Department, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Meng J; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Zhao W; Chinese PLA Medical School, Beijing, China.
  • Xie F; Pulmonary and Critical Care Medicine Department, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Wang K; Pulmonary and Critical Care Medicine Department, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Liu Y; Naval Clinical College, Anhui Medical University, Hefei, China.
  • Muo G; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Xi N; Pulmonary and Critical Care Medicine Department, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Zheng M; Pulmonary and Critical Care Medicine Department, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Wang R; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Xiao K; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Chen W; Pharmacy Department, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Xiong J; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Zhao D; Chinese PLA Medical School, Beijing, China.
  • Zhang X; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Han X; Chinese PLA Medical School, Beijing, China.
  • Cheng H; College of Pulmonary and Critical Care Medicine, The Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Yu Z; Chinese PLA Medical School, Beijing, China.
  • Shi Y; Pulmonary and Critical Care Medicine Department, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Xie W; Pulmonary and Critical Care Medicine Department, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Xie L; Pulmonary and Critical Care Medicine Department, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China.
Ann Med ; 56(1): 2313062, 2024 12.
Article in En | MEDLINE | ID: mdl-38354691

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proline / Ritonavir / COVID-19 / Lactams / Leucine / Nitriles Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Ann Med Journal subject: MEDICINA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proline / Ritonavir / COVID-19 / Lactams / Leucine / Nitriles Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Ann Med Journal subject: MEDICINA Year: 2024 Document type: Article Affiliation country: Country of publication: